Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapy.

Humans Carcinoma, Non-Small-Cell Lung Phylogeny RNA, Ribosomal, 16S / genetics Lung Neoplasms Immunotherapy Fatty Acids Feces
Bacteria Cancer Gabonibacter chumensis Gut microbiota Immunotherapy Non-small cell lung cancer

Journal

Archives of microbiology
ISSN: 1432-072X
Titre abrégé: Arch Microbiol
Pays: Germany
ID NLM: 0410427

Informations de publication

Date de publication:
24 Sep 2023
Historique:
received: 13 02 2023
accepted: 29 08 2023
revised: 21 08 2023
medline: 26 9 2023
pubmed: 24 9 2023
entrez: 24 9 2023
Statut: epublish

Résumé

A polyphasic taxonomic approach, incorporating analysis of phenotypic features, cellular fatty acid profiles, 16S rRNA gene sequences, and determination of average nucleotide identity (ANI) plus digital DNA-DNA hybridization (dDDH), was applied to characterize an anaerobic bacterial strain designated KD22

Identifiants

DOI: 10.1007/s00203-023-03671-0 PMID: 37742282 PMC: PMC10518271
pubmed: 37742282
doi: 10.1007/s00203-023-03671-0
pii: 10.1007/s00203-023-03671-0
pmc: PMC10518271
doi:

Substances chimiques

RNA, Ribosomal, 16S 0
Fatty Acids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

338

Subventions

Organisme : CIHR
ID : Canada 150 Research Chair in Bacterial Cell Biology
Pays : Canada
Organisme : CIHR
ID : Canada 150 Research Chair in Bacterial Cell Biology
Pays : Canada
Organisme : CIHR
ID : 437944
Pays : Canada
Organisme : CIHR
ID : 420356
Pays : Canada

Informations de copyright

© 2023. The Author(s).

Références

Cancer Lett. 2019 Apr 10;447:41-47
pubmed: 30684593
Cancer Discov. 2021 Oct;11(10):2396-2412
pubmed: 34400407
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Methods Enzymol. 1996;266:383-402
pubmed: 8743695
Am J Respir Crit Care Med. 2015 Feb 15;191(4):377-90
pubmed: 25369536
Int J Syst Evol Microbiol. 2014 Feb;64(Pt 2):346-351
pubmed: 24505072
BMC Bioinformatics. 2013 Feb 21;14:60
pubmed: 23432962
Int J Antimicrob Agents. 2014 Aug;44(2):117-24
pubmed: 25063078
Int J Syst Evol Microbiol. 2007 Jan;57(Pt 1):81-91
pubmed: 17220447
Int J Syst Evol Microbiol. 2018 Jan;68(1):461-466
pubmed: 29292687
Mol Biol Evol. 2017 Oct 1;34(10):2627-2636
pubmed: 28957503
Mol Biol Evol. 2021 Jan 23;38(2):727-734
pubmed: 32886787
Nat Microbiol. 2016 Nov 07;1:16203
pubmed: 27819657
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Curr Microbiol. 2016 Dec;73(6):867-877
pubmed: 27628331
J Clin Microbiol. 2013 Jul;51(7):2182-94
pubmed: 23637301
Cancer Cell. 2018 Apr 9;33(4):570-580
pubmed: 29634945
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Oncol Ther. 2021 Dec;9(2):647-657
pubmed: 34664203
Nat Rev Microbiol. 2014 Sep;12(9):635-45
pubmed: 25118885
Arch Bronconeumol (Engl Ed). 2019 Mar;55(3):124-125
pubmed: 30297242
Clin Microbiol Rev. 2015 Jan;28(1):237-64
pubmed: 25567229
Stand Genomic Sci. 2010 Jan 28;2(1):117-34
pubmed: 21304684
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Clin Infect Dis. 2009 Aug 15;49(4):543-51
pubmed: 19583519
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
pubmed: 7984417

Auteurs

Khoudia Diop (K)

Laboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada. khoudia.diop@umontreal.ca.

Reilly Pidgeon (R)

Department of Pharmacology & Therapeutics, Faculty of Medicine and Health Sciences, McGill University, 3655 Promenade Sir-William-Osler, Montreal, QC, H3G 1Y6, Canada.

Awa Diop (A)

Department of Biology, University of North Carolina Greensboro, 321 McIver Street, PO Box 26170, Greensboro, NC, 27402, USA.

Myriam Benlaïfaoui (M)

Laboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada.

Wiam Belkaid (W)

Laboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada.

Julie Malo (J)

Laboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada.

Eve Bernet (E)

INRS-Centre Armand-Frappier Santé Biotechnologie, Bacterial Symbionts Evolution, Laval, QC, H7V 1B7, Canada.

Frederic Veyrier (F)

INRS-Centre Armand-Frappier Santé Biotechnologie, Bacterial Symbionts Evolution, Laval, QC, H7V 1B7, Canada.

Maxime Jacq (M)

Faculty of Medicine, Department of Microbiology and Immunology, University of Montreal, Montreal, QC, Canada.

Yves Brun (Y)

Faculty of Medicine, Department of Microbiology and Immunology, University of Montreal, Montreal, QC, Canada.

Arielle Elkrief (A)

Laboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada.

Bastien Castagner (B)

Department of Pharmacology & Therapeutics, Faculty of Medicine and Health Sciences, McGill University, 3655 Promenade Sir-William-Osler, Montreal, QC, H3G 1Y6, Canada.

Bertrand Routy (B)

Laboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada. bertrand.routy@umontreal.ca.
Hematology-Oncology Service, Department of Medicine, University of Montreal Healthcare Centre (CHUM), Montreal, QC, H2X 0A9, Canada. bertrand.routy@umontreal.ca.

Corentin Richard (C)

Laboratory of Immunotherapy and Onco-Microbiome, University of Montreal Healthcare Research Center (CRCHUM), 900 Rue Saint-Denis, Montreal, QC, H2X 0A9, Canada.

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Characterization and description of...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Tumeurs des bronches › Carcinome bronchogénique › Carcinome pulmonaire non à petites cellules › Characterization and description of...
questionsmedicales.fr › Sciences de l'information › Phylogenèse › Characterization and description of...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN ribosomique › ARN ribosomique 16S › Characterization and description of...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Characterization and description of...
questionsmedicales.fr › Thérapeutique › Biothérapie › Immunothérapie › Characterization and description of...
questionsmedicales.fr › Lipides › Acides gras › Characterization and description of...
questionsmedicales.fr › Liquides et sécrétions biologiques › Fèces › Characterization and description of...